Vitamin B12 Supplementation: Preventing Onset and Improving Prognosis of Depression.

depression prevention hyperhomocysteinemia neuro-psychiatric serum vitamin b12

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
26 Oct 2020
Historique:
entrez: 30 11 2020
pubmed: 1 12 2020
medline: 1 12 2020
Statut: epublish

Résumé

Depression is a common mental health condition occurring across all ages, genders, and populations and is almost always multifaceted. It can manifest as a form of metabolic disorder, endocrine disorder, cardiovascular diseases, inflammatory disorders, deficiencies, or neurodegenerative disorders. Although there have been various treatment options available for the treatment of depression, it is still a sizable global health concern requiring more attention. This review article was produced by researching data and studies to prove a relationship between Vitamin B12 and depression. Numerous studies were reviewed, and based on these studies, it was concluded that supplementation of Vitamin B12 early enough can delay the onset of depression and improve the effect of anti-depressants when used in conjunction with Vitamin B12. Although other vitamins like Vitamin B6 and folate are known to have an impact on depression, we have primarily focused on Vitamin B12 in an attempt to offer the providers a foundation to address this concern with their patients prone to depression or have had a major depressive episode in their life.

Identifiants

pubmed: 33251075
doi: 10.7759/cureus.11169
pmc: PMC7688056
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e11169

Informations de copyright

Copyright © 2020, Sangle et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Res Nurs Health. 2019 Aug;42(4):264-272
pubmed: 31119757
Crit Rev Food Sci Nutr. 2016 Nov 17;56(15):2560-2578
pubmed: 25365455
Psychosomatics. 2011 Jul-Aug;52(4):384-6
pubmed: 21777723
Blood. 1990 Sep 1;76(5):871-81
pubmed: 2393714
PLoS One. 2016 Jan 22;11(1):e0146797
pubmed: 26799654
Am J Clin Nutr. 2007 Jan;85(1):193-200
pubmed: 17209196
Am Fam Physician. 2003 Mar 1;67(5):979-86
pubmed: 12643357
Int J Environ Res Public Health. 2018 Jun 09;15(6):
pubmed: 29890739
BMC Psychiatry. 2003 Dec 02;3:17
pubmed: 14641930
Am J Clin Nutr. 2000 Sep;72(3):762-9
pubmed: 10966896
J Nutr Health Aging. 2002;6(1):39-42
pubmed: 11813080
Health Promot Perspect. 2012 Dec 28;2(2):145-52
pubmed: 24688928
J Am Soc Nephrol. 2001 Oct;12(10):2181-9
pubmed: 11562419
Compr Psychiatry. 1997 Nov-Dec;38(6):305-14
pubmed: 9406735
Eur Neuropsychopharmacol. 2017 Nov;27(11):1090-1109
pubmed: 28988944
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Sep;29(7):1103-12
pubmed: 16109454
Kidney Int Suppl. 2003 May;(84):S131-3
pubmed: 12694328
Eur J Clin Nutr. 2014 May;68(5):541-8
pubmed: 24667752
BMC Psychiatry. 2013 May 24;13:145
pubmed: 23705786
Am J Clin Nutr. 2010 Aug;92(2):330-5
pubmed: 20519557
Open Neurol J. 2013 Nov 15;7:44-8
pubmed: 24339839
Curr Med Chem. 2016;23(38):4317-4337
pubmed: 27655070
J Am Med Dir Assoc. 2019 May;20(5):551-557.e1
pubmed: 30692033
BMC Psychiatry. 2020 Feb 13;20(1):63
pubmed: 32054533
Cochrane Database Syst Rev. 2003;(4):CD004514
pubmed: 14584018
Am J Clin Nutr. 2012 Jan;95(1):194-203
pubmed: 22170358
Child Adolesc Ment Health. 2020 Nov;25(4):249-255
pubmed: 32304285
Int J Neuropsychopharmacol. 2020 May 13;:
pubmed: 32402075
Neurosciences (Riyadh). 2017 Jul;22(3):228-232
pubmed: 28678220
J Nutr. 2012 Aug;142(8):1554-60
pubmed: 22739363
Arch Intern Med. 2007 Jan 8;167(1):21-30
pubmed: 17210874
Neurology. 2008 Sep 9;71(11):826-32
pubmed: 18779510

Auteurs

Prerna Sangle (P)

Family Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Osama Sandhu (O)

Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Zarmeena Aftab (Z)

Family Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Adarsh Thomas Anthony (AT)

Family Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Safeera Khan (S)

Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Classifications MeSH